Logo image of WTRH

WAITR HOLDINGS INC (WTRH) Stock Fundamental Analysis

NASDAQ:WTRH - Nasdaq - US9307521008 - Common Stock - Currency: USD

0.0931  -0.01 (-5.96%)

After market: 0.0949 +0 (+1.93%)

Fundamental Rating

1

Overall WTRH gets a fundamental rating of 1 out of 10. We evaluated WTRH against 0 industry peers in the Internet & Direct Marketing Retail industry. WTRH may be in some trouble as it scores bad on both profitability and health. WTRH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

WTRH had negative earnings in the past year.
WTRH had a negative operating cash flow in the past year.
WTRH Yearly Net Income VS EBIT VS OCF VS FCFWTRH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 -100M -200M

1.2 Ratios

Industry RankSector Rank
ROA -188.06%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WTRH Yearly ROA, ROE, ROICWTRH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -1K -2K -3K -4K -5K

1.3 Margins

Industry RankSector Rank
OM -21.47%
PM (TTM) -131.13%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WTRH Yearly Profit, Operating, Gross MarginsWTRH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -50 -100 -150

1

2. Health

2.1 Basic Checks

WTRH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WTRH has been increased compared to 1 year ago.
WTRH has a better debt/assets ratio than last year.
WTRH Yearly Shares OutstandingWTRH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M
WTRH Yearly Total Debt VS Total AssetsWTRH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -7.64, we must say that WTRH is in the distress zone and has some risk of bankruptcy.
WTRH has a Debt/Equity ratio of 14.59. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 14.59
Debt/FCF N/A
Altman-Z -7.64
ROIC/WACCN/A
WACC6.08%
WTRH Yearly LT Debt VS Equity VS FCFWTRH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M

2.3 Liquidity

WTRH has a Current Ratio of 1.05. This is a normal value and indicates that WTRH is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.05 indicates that WTRH should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
WTRH Yearly Current Assets VS Current LiabilitesWTRH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

3

3. Growth

3.1 Past

WTRH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -666.67%.
Looking at the last year, WTRH shows a very negative growth in Revenue. The Revenue has decreased by -31.72% in the last year.
WTRH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 99.95% yearly.
EPS 1Y (TTM)-666.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)-31.72%
Revenue growth 3Y38.02%
Revenue growth 5Y99.95%
Sales Q2Q%-42.14%

3.2 Future

Based on estimates for the next years, WTRH will show a very strong growth in Earnings Per Share. The EPS will grow by 32.38% on average per year.
The Revenue is expected to decrease by -20.41% on average over the next years. This is quite bad
EPS Next Y-74.86%
EPS Next 2Y6.1%
EPS Next 3Y34.42%
EPS Next 5Y32.38%
Revenue Next Year-33.53%
Revenue Next 2Y-20.64%
Revenue Next 3Y-20.75%
Revenue Next 5Y-20.41%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WTRH Yearly Revenue VS EstimatesWTRH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
WTRH Yearly EPS VS EstimatesWTRH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2 -3 -4

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WTRH. In the last year negative earnings were reported.
Also next year WTRH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WTRH Price Earnings VS Forward Price EarningsWTRH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -3.73
WTRH Per share dataWTRH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6

4.3 Compensation for Growth

WTRH's earnings are expected to grow with 34.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.1%
EPS Next 3Y34.42%

0

5. Dividend

5.1 Amount

WTRH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

WAITR HOLDINGS INC

NASDAQ:WTRH (11/21/2022, 8:13:38 PM)

After market: 0.0949 +0 (+1.93%)

0.0931

-0.01 (-5.96%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryInternet & Direct Marketing Retail
Earnings (Last)11-09 2022-11-09/amc
Earnings (Next)03-09 2023-03-09
Inst Owners0.37%
Inst Owner Change0%
Ins Owners8.96%
Ins Owner Change0%
Market Cap19.22M
Analysts82.86
Price Target2.04 (2091.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-56.86%
Min EPS beat(2)-96.08%
Max EPS beat(2)-17.65%
EPS beat(4)1
Avg EPS beat(4)-44.96%
Min EPS beat(4)-96.08%
Max EPS beat(4)29.97%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-22.45%
Min Revenue beat(2)-35.82%
Max Revenue beat(2)-9.08%
Revenue beat(4)1
Avg Revenue beat(4)-14.01%
Min Revenue beat(4)-35.82%
Max Revenue beat(4)1.04%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF N/A
P/OCF N/A
P/B 5.01
P/tB N/A
EV/EBITDA -3.73
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.63
BVpS0.02
TBVpS-0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -188.06%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -21.47%
PM (TTM) -131.13%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 14.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 67.95%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z -7.64
F-Score2
WACC6.08%
ROIC/WACCN/A
Cap/Depr(3y)56.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-666.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y-74.86%
EPS Next 2Y6.1%
EPS Next 3Y34.42%
EPS Next 5Y32.38%
Revenue 1Y (TTM)-31.72%
Revenue growth 3Y38.02%
Revenue growth 5Y99.95%
Sales Q2Q%-42.14%
Revenue Next Year-33.53%
Revenue Next 2Y-20.64%
Revenue Next 3Y-20.75%
Revenue Next 5Y-20.41%
EBIT growth 1Y-1158.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-95.44%
EBIT Next 3Y37.84%
EBIT Next 5Y23.65%
FCF growth 1Y-1217.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-416.27%
OCF growth 3YN/A
OCF growth 5YN/A